PURPURA, THROMBOCYTOPENIC

Clinical trials for PURPURA, THROMBOCYTOPENIC explained in plain language.

Never miss a new study

Get alerted when new PURPURA, THROMBOCYTOPENIC trials appear

Sign up with your email to follow new studies for PURPURA, THROMBOCYTOPENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Could one daily aspirin pill fail to protect these patients from heart attacks?

Disease control Completed

This study investigated whether a standard daily low-dose aspirin pill is enough to prevent blood clots in adults who have both a rare bleeding disorder (immune thrombocytopenia) and heart disease. Researchers measured how well aspirin worked in the body 24 hours after a dose in …

Matched conditions: PURPURA, THROMBOCYTOPENIC

Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

PURPURA, THROMBOCYTOPENIC

Get alerted when new PURPURA, THROMBOCYTOPENIC trials appear

Could one daily aspirin pill fail to protect these patients from heart attacks?